Catalyst Event
Guardant Health Inc (GH) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/7/2026, 12:00:00 AM
Reported Q1 2026 revenue of $301.7 million, a 48% increase year-over-year, beating analyst expectations. The company raised its full-year 2026 revenue guidance to $1.30-$1.32 billion. High importance estimated due to significant revenue beat and guidance raise; expected.
Korean Translation
2026년 1분기 매출이 전년 동기 대비 48% 증가한 3억 170만 달러를 기록하여 분석가 예상을 상회하였으며, 2026년 연간 매출 가이던스를 13억~13억 2천만 달러로 상향 조정함. 매출 상회 및 가이던스 상향으로 인한 높은 중요도가 예상됨.
Related Recent Events
JD Health International Inc (6618) · Earnings Release
Low importance estimated as no market reaction has occurred yet; Q2 2026 earnings report scheduled.
8/12/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the final dividend of RMB 1.43 per 10 shares, scheduled to be paid on July 13, 2026. Low importance estimated as the dividend amount is within historical norms, scheduled.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date (2026-06-12) for the proposed 2025 final dividend of HK$0.169 per share is scheduled.
6/12/2026, 12:00:00 AM
Veracyte Inc (VCYT) · Other
Annual Meeting of Stockholders on 2026-06-10, with proposals including the election of directors and an expansion of the 2023 Equity Incentive Plan scheduled.
6/10/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Pacific Biosciences of California Inc (PACB) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, including a proposal to increase the number of shares reserved for the 2020 Equity Incentive Plan by 16,000,000. A low impact is estimated due to potential share dilution, scheduled.
6/3/2026, 12:00:00 AM